首页> 外文期刊>JAMA dermatology >Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum Two Phase 3 Randomized Clinical Trials
【24h】

Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum Two Phase 3 Randomized Clinical Trials

机译:VP-102的安全性和功效,含有鹅肝菌素,0.7%(W / V),儿童和成人的专有,药物 - 装置组合产物,具有软体动物胶囊的儿童和成人两相3随机临床试验

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

IMPORTANCE Molluscum contagiosum (MC) is a common viral skin infection that primarily affects children. Cantharidin, a topical vesicant, has a long history of use for MC in compounded formulations, but the safety and efficacy of doses, regimens, and application methods have not been demonstrated in large-scale trials.
机译:传染性软体动物(MC)是一种常见的病毒性皮肤感染,主要影响儿童。斑蝥素是一种局部发泡剂,在复合配方中用于MC已有很长的历史,但剂量、方案和应用方法的安全性和有效性尚未在大规模试验中得到证明。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号